Noriko Kobayashi
- Molecular Biology top 10%
- Cancer Research top 5%
- Epidemiology top 10%
- Obstetrics and Gynecology top 2%
- Reproductive Medicine top 5%
- Co-authors
- Hidemichi WatariPeixin DongJunming YueYing XiongYukiharu TodoMaki NiiokaHitoshi EndoMamoru Tanaka
- Topics
- Pharmacy and Medical Practices (10 papers)Cancer-related molecular mechanisms research (8 papers)Endometrial and Cervical Cancer Treatments (8 papers)
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEEndocrinology
- Partner nations
- JapanUnited StatesChina
In The Last Decade
Noriko Kobayashi
87 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 130
- Molecular Biology 834
- Cancer Research 500
- Epidemiology 293
- Obstetrics and Gynecology 247
- Reproductive Medicine 216
Countries citing papers authored by Noriko Kobayashi
This map shows the geographic impact of Noriko Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noriko Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noriko Kobayashi more than expected).
Fields of papers citing papers by Noriko Kobayashi
This network shows the impact of papers produced by Noriko Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noriko Kobayashi. The network helps show where Noriko Kobayashi may publish in the future.
Co-authorship network of co-authors of Noriko Kobayashi
This figure shows the co-authorship network connecting the top 25 collaborators of Noriko Kobayashi. A scholar is included among the top collaborators of Noriko Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noriko Kobayashi. Noriko Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 0 | |
| 6 | 58 | |
| 7 | 3 | |
| 8 | 4 | |
| 9 | 7 | |
| 10 | 20 | |
| 11 | 119 | |
| 12 | 13 | |
| 13 | 1 | |
| 14 | 274 | |
| 15 | 0 | |
| 16 | 10 | |
| 17 | 6 | |
| 18 | 10 | |
| 19 | 23 | |
| 20 | What Does a "Simple Performance-Oriented Test" Measure? | 1 |
About Noriko Kobayashi
Noriko Kobayashi is a scholar working on Obstetrics and Gynecology, Pharmacology and Geriatrics and Gerontology, having authored 97 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pharmacy and Medical Practices (10 papers), Cancer-related molecular mechanisms research (8 papers) and Endometrial and Cervical Cancer Treatments (8 papers). The work is most often cited by research in Cancer Research (500 citations), Obstetrics and Gynecology (247 citations) and Reproductive Medicine (216 citations). Noriko Kobayashi has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Hidemichi Watari, Peixin Dong, Junming Yue, Ying Xiong, Yukiharu Todo, Maki Niioka, Hitoshi Endo, Mamoru Tanaka, Tetsu Watanabe and Noriaki Sakuragi. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.